Latest Market Strategy News

Blackpearl Group has reported a landmark $26.8 million in Annual Recurring Revenue (ARR) for Q4 FY26, marking a 114% year-on-year increase. With zero churn in its Data as a Service (DaaS) segment and improved customer acquisition efficiency, the company is now prioritising optimisation to accelerate cash flow and tighten customer profiles.

Eden Innovations has unveiled EdenShield®, a new division focused on commercialising advanced carbon nanotube-enhanced materials and dual-fuel systems for defence and critical infrastructure, aiming to tap into a rapidly expanding global aerospace and defence market.

Ryman Healthcare’s FY26 retirement living sales hit 1,410 ORAs, aligning with guidance despite a Q4 dip in new sales. The company reports robust aged care occupancy and expects free cash flow near NZD 180 million.

Zeotech Limited has made significant progress on its Toondoon Kaolin Project, securing critical environmental approvals, advancing mine planning, and preparing for an initial kaolin shipment amid rising contractor cost pressures.

Harvest Technology Group has secured independent validation of its Nodestream platform's strong fit within the US defence sector, highlighting a clear pathway for market entry focused on bandwidth-constrained communications.

Audeara Ltd has posted its second straight quarter of positive operating cash flow, driven by a record Australian wholesale order and expanding technology licensing deals. The company’s cash balance rose to $1.05 million as it advances global market expansions.

GQG Partners reported a decline in funds under management to USD 162.5 billion at the end of March 2026, driven by significant net outflows partially offset by strong investment returns amid market volatility.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

360 Capital Mortgage REIT has initiated an on-market buy-back and reaffirmed its FY26 earnings guidance, signalling confidence amid a narrowing discount to net asset value.

Eagers Automotive is broadening its Australian footprint through strategic investments in multi-brand dealerships and premium Audi outlets, while advancing its international ambitions with CanadaOne Auto.

Andromeda Metals faces uncertainty in securing cornerstone funding for its Great White Project due to Middle East geopolitical tensions, while pushing forward with its High Purity Alumina pilot plant commissioning.